Inventor · disambiguated record
Ryan Fleming
Also filed as: FLEMING RYAN
7 granted patents·5 pending applications·19 citations·filing 2012–2025
80Inventor score
Top patents by PatentIndex Score
12 records- 0190US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0289US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 0384US10160812B2Bispecific HER2 antibodiesMEDIMMUNE LLC·Filed 2015·Granted Dec 25, 2018·4 cites·18 claims
- 0481US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 0577US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0672US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 0766US11566068B2Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2020·Granted Jan 31, 2023·0 cites·4 claims
- 0861US10836819B2Anti-VEGF-A and anti-ANG2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2017·Granted Nov 17, 2020·0 cites·7 claims
- 0958US2025051463A1Cd123 antibody-drug conjugates and methods of using the sameASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1048US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 1145US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 1236US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryan Fleming files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →